Dr Patrick Dodds

Material corrosion is a cross-sector problem that costs industry potentially $500 billion globally each year. Current anti-corrosion chemicals contain hexavalent chromate, a highly toxic chemical that will be banned from use in the EU from 2019. The need for alternatives is pressing, and Dr Patrick Dodds, CEO and Founder of Hexigone Inhibitors Ltd, has found a novel Patrick Doddssolution.

Dr Dodds’ anti-corrosion technology is not simply a chemical, but a system of nano-reservoirs that can be incorporated into coatings such as paint. This technology is activated by the chemicals that cause corrosion, triggering the rapid release of a protective agent and essentially making the coated material self-healing.

The aerospace, automotive and shipping industries are among those currently searching for new anti-corrosion solutions. Dr Dodds’ technology has potential to penetrate the £200 billion-dollar protective coating industry thanks to its speed of action and environmental acceptability. It also aims to match current equivalents on price and the length of its guarantee.

Awards from the Worshipful Company of Armourers & Brasiers, Royal Society and Innovate UK have supported proof of concept and development to date. Dr Dodds is now developing this novel technology in collaboration with Tata Steel to manufacture anti-corrosive paint for metals in Europe. Discussions are progressing with other investors, and there has been interest from several multinationals within the paint industry.

Dr Dodds was awarded a 2017 Enterprise Fellowship to support him to develop the business. Next steps involve scaling up the manufacturing process and both long-term and accelerated testing.


Subscribe to our mailing list and get updates!

Do you want to become a member, a mentor or just want to support us?

Find out more >